GlassScriptPhysician profile
Surendra S Barshikar
NPI 1366684920
$10,789.11
in general payments reported to CMS, 2019-2025
13 companies · $108 in 2025
The $108 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,753 · 2020: $609 · 2022: $133 · 2023: $7,881 · 2024: $304 · 2025: $108.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,186 · Travel and Lodging: $1,579 · Food and Beverage: $529.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,185.50 |
| Travel and Lodging | $1,579.05 |
| Food and Beverage | $528.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $7,764.55 | 2023 | Nuedexta |
| Avanir Pharmaceuticals, INC. | $946.76 | 2019 | |
| Allergan, INC. | $834.95 | 2019-2020 | |
| Ipsen Biopharmaceuticals, INC | $479.13 | 2019-2025 | Dysport |
| Mdd US Operations, LLC | $153.34 | 2019 | |
| Abbvie INC. | $153.15 | 2022-2025 | Botox |
| Merz North America, INC. | $152.95 | 2019 | |
| Saol Therapeutics INC. | $116.36 | 2019 | |
| Csl Behring | $86.00 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $72.96 | 2024 | Exparel |
| Tersera Therapeutics LLC | $15.96 | 2023 | Prialt |
| Merz Pharmaceuticals, LLC | $13.00 | 2023 | Xeomin |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Surendra Barshikar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.